[Radiosynoviorthesis of the thumb's carpometacarpal joint].

Mingels, Clemens; Daneshvar, Keivan; Afshar-Oromieh, Ali (2022). [Radiosynoviorthesis of the thumb's carpometacarpal joint]. Der Orthopäde, 51(1), pp. 9-12. Springer 10.1007/s00132-021-04194-6

Text Mingels2022_Article_RadiosynoviortheseDesDaumensat.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (516kB)

Radiosynoviorthesis (RSO) is an established therapeutic method for the local treatment of pain in aseptic joint inflammation (e.g. arthritis, activated osteoarthritis, synovitis). RSO can be used for the treatment of synovial membrane inflammation of the finger joints such as the thumb's carpometacarpal joint. The beta emitter Erbium-169 (Er-169) is injected into the joint space, which irradiates the inflamed synovialis, thereby leading to fibrosis and obliteration of the pain receptors of the synovial membrane. The chances of success in the treatment of the thumb's carpometacarpal joint by RSO are estimated to be 54-100% within 2-6 weeks after therapy.

Interest & Impact

Downloads

2 since deposited on 19 Jan 2022
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item